The prevalence of obesity and associated comorbidities is rising. This material summarized the anti-obesity medications adapted by the PES Obesity Special Interest Group from the original…
Read More
This is a perspective that very briefly summarizes the evidence at that time of publication for treatment of youth-onset type 2 diabetes, as well as some…
Read More
Prepared by Bhuvana Sunil, MD and Ambika Ashraf, MD Burosumab twza (Crysvita – Ultragenyx pharmaceuticals) is an injectable recombinant IgG1 human monoclonal antibody preparation neutralizing fibroblast…
Read More
Prepared by Christine Yu and Amit Lahoti Semglee™ is a new biosimilar insulin with an identical amino-acid sequence to insulin glargine. Semglee™, co-developed by Mylan Inc.…
Read More
Prepared by: Seth Marks and Amit Lahoti Updated July 22, 2020 The FreeStyle Libre 2 is the second generation of Abbott Laboratories’ flash glucose monitoring system.…
Read More
Riomet ER™ (metformin hydrochloride for extended-release oral suspension) was approved by the U.S. Food and Drug Administration (USFDA) on August 29, 2019 and became available in…
Read More